On Monday, Amarin Corp ADR (NASDAQ: AMRN) opened higher 8.83% from the last session, before settling in for the closing price of $0.58. Price fluctuations for AMRN have ranged from $0.56 to $1.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 14.60%. Company’s average yearly earnings per share was noted -5.46% at the time writing. With a float of $409.78 million, this company’s outstanding shares have now reached $411.11 million.
Let’s determine the extent of company efficiency that accounts for 275 employees. In terms of profitability, gross margin is 55.67%, operating margin of -15.14%, and the pretax margin is -10.18%.
Amarin Corp ADR (AMRN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Amarin Corp ADR is 0.32%, while institutional ownership is 19.37%. The most recent insider transaction that took place on Aug 02 ’24, was worth 102,400. In this transaction President and CEO of this company bought 160,000 shares at a rate of $0.64, taking the stock ownership to the 805,380 shares. Before that another transaction happened on Jan 22 ’24, when Company’s President and CEO bought 14,426 for $1.09, making the entire transaction worth $15,724. This insider now owns 314,426 shares in total.
Amarin Corp ADR (AMRN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -5.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.90% during the next five years compared to 17.93% growth over the previous five years of trading.
Amarin Corp ADR (NASDAQ: AMRN) Trading Performance Indicators
Check out the current performance indicators for Amarin Corp ADR (AMRN). In the past quarter, the stock posted a quick ratio of 2.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Amarin Corp ADR (AMRN)
Looking closely at Amarin Corp ADR (NASDAQ: AMRN), its last 5-days average volume was 1.1 million, which is a drop from its year-to-date volume of 1.55 million. As of the previous 9 days, the stock’s Stochastic %D was 64.37%. Additionally, its Average True Range was 0.03.
During the past 100 days, Amarin Corp ADR’s (AMRN) raw stochastic average was set at 28.55%, which indicates a significant decrease from 83.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.09% in the past 14 days, which was lower than the 63.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5995, while its 200-day Moving Average is $0.8282. However, in the short run, Amarin Corp ADR’s stock first resistance to watch stands at $0.6638. Second resistance stands at $0.6941. The third major resistance level sits at $0.7394. If the price goes on to break the first support level at $0.5882, it is likely to go to the next support level at $0.5429. Now, if the price goes above the second support level, the third support stands at $0.5126.
Amarin Corp ADR (NASDAQ: AMRN) Key Stats
There are currently 410,672K shares outstanding in the company with a market cap of 260.44 million. Presently, the company’s annual sales total 306,910 K according to its annual income of -59,110 K. Last quarter, the company’s sales amounted to 67,490 K and its income totaled 1,520 K.
